No Data
No Data
No Data
No Data
No Data
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live
GlobeNewswireApr 17 07:00 ET
Banzai Welcomes Over 580 New Customers In Q1, A Quarterly Increase Of 46%
Banzai International, Inc. (NASDAQ:BNZI), a leading marketing technology company providing essential marketing and sales solutions, announced exceptional customer growth in Q1 2024. Banzai added over
BenzingaApr 16 08:04 ET
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Seeking AlphaApr 14 17:56 ET
Needham Reiterates Buy on Enovis, Maintains $82 Price Target
Needham analyst Mike Matson reiterates Enovis (NYSE:ENOV) with a Buy and maintains $82 price target.
BenzingaApr 10 08:18 ET
Not Many Are Piling Into Enovis Corporation (NYSE:ENOV) Just Yet
You may think that with a price-to-sales (or "P/S") ratio of 2x Enovis Corporation (NYSE:ENOV) is a stock worth checking out, seeing as almost half of all the Medical Equipment companies in the United
Simply Wall StApr 1 09:49 ET
Only 4.8% increase in 2024? Needham is cautious about the recovery of the orthopedic device market
A recent analysis by Needham, a well-known Wall Street investment agency, shows that the backlog of surgeries associated with the pandemic will drive sales of orthopedic medical devices this year.
Zhitong FinanceApr 1 02:40 ET
No Data
No Data